• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Concurrent once-daily or twice-daily chemoradiotherapy in limited-stage small-cell lung cancer?].

作者信息

Frosch Susanne, Troost Esther G C

机构信息

Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland.

OncoRay - Nationales Zentrum für Strahlenforschung in der Onkologie, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden, Dresden, Deutschland.

出版信息

Strahlenther Onkol. 2018 Jan;194(1):73-75. doi: 10.1007/s00066-017-1234-6.

DOI:10.1007/s00066-017-1234-6
PMID:29143097
Abstract
摘要

相似文献

1
[Concurrent once-daily or twice-daily chemoradiotherapy in limited-stage small-cell lung cancer?].[局限期小细胞肺癌每日一次或每日两次同步放化疗？]
Strahlenther Onkol. 2018 Jan;194(1):73-75. doi: 10.1007/s00066-017-1234-6.
2
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).诱导化疗和同期放化疗后可切除 IIIA(N2)和部分 IIIB 期非小细胞肺癌患者的手术与根治性同期放化疗增敏的 III 期研究（ESPATUE）
J Clin Oncol. 2015 Dec 10;33(35):4194-201. doi: 10.1200/JCO.2015.62.6812. Epub 2015 Nov 2.
3
Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer.每日两次胸部放疗的疗程以及从任何治疗开始至胸部照射结束的时间，作为局限期小细胞肺癌预后的重要预测因素。
Clin Lung Cancer. 2017 Mar;18(2):e117-e127. doi: 10.1016/j.cllc.2016.09.004. Epub 2016 Oct 3.
4
Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.对接受放化疗的局限性疾病小细胞肺癌患者局部区域失败和生存相关因素的评估。
Acta Oncol. 2015;54(9):1574-81. doi: 10.3109/0284186X.2015.1062135. Epub 2015 Jul 23.
5
Evaluation of a treatment strategy for optimising preoperative chemoradiotherapy in stage III non-small-cell lung cancer.评估一种优化 III 期非小细胞肺癌术前放化疗的治疗策略。
Eur J Cardiothorac Surg. 2009 Dec;36(6):1052-7. doi: 10.1016/j.ejcts.2009.05.025. Epub 2009 Jul 17.
6
A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.一项针对局部晚期非小细胞肺癌老年患者的诱导化疗后序贯同步放化疗的II期研究。
Anticancer Drugs. 2007 Jul;18(6):713-9. doi: 10.1097/CAD.0b013e328082558a.
7
Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer.术前每日两次放疗及同步化疗对IIIA期非小细胞肺癌肿瘤降期及切除率改善的生存潜在影响。
J Clin Oncol. 1997 Feb;15(2):712-22. doi: 10.1200/JCO.1997.15.2.712.
8
[Concurrent chemoradiotherapy followed by consolidation chemotherapy and sequential chemoradiotherapy for stage III non-small cell lung cancer: comparison in 93 patients].[同步放化疗序贯巩固化疗与序贯放化疗治疗Ⅲ期非小细胞肺癌：93例患者的比较]
Nan Fang Yi Ke Da Xue Xue Bao. 2012 Mar;32(3):362-7.
9
[Combined-modality therapy for lung cancer].[肺癌的综合治疗]
Nihon Rinsho. 2010 Jun;68(6):1121-8.
10
Preoperative concurrent chemoradiotherapy of S-1/cisplatin for stage III non-small cell lung cancer.术前 S-1/顺铂同步放化疗治疗 III 期非小细胞肺癌。
Ann Thorac Surg. 2013 Nov;96(5):1783-9. doi: 10.1016/j.athoracsur.2013.06.036. Epub 2013 Aug 30.

本文引用的文献

1
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.局限期小细胞肺癌患者同步每日一次与每日两次放化疗的比较（CONVERT）：一项开放标签、3期、随机、优效性试验
Lancet Oncol. 2017 Aug;18(8):1116-1125. doi: 10.1016/S1470-2045(17)30318-2. Epub 2017 Jun 20.
2
Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer.局限期小细胞肺癌患者采用低分割或常规分割放疗联合化疗。
Radiat Oncol. 2017 Mar 11;12(1):51. doi: 10.1186/s13014-017-0788-x.
3
Recent Advances and Future Strategies for Immune-Checkpoint Inhibition in Small-Cell Lung Cancer.
小细胞肺癌免疫检查点抑制的最新进展与未来策略
Clin Lung Cancer. 2017 Mar;18(2):132-140. doi: 10.1016/j.cllc.2016.07.004. Epub 2016 Jul 9.
4
Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC.一项关于伊匹木单抗联合卡铂和依托泊苷作为广泛期小细胞肺癌一线治疗的多中心2期研究的结果及生物标志物分析
J Thorac Oncol. 2016 Sep;11(9):1511-21. doi: 10.1016/j.jtho.2016.05.028. Epub 2016 Jun 11.
5
Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials.局限期小细胞肺癌患者胸部放疗的时机：随机对照试验的系统评价和荟萃分析
Cancer Treat Rev. 2007 Aug;33(5):461-73. doi: 10.1016/j.ctrv.2007.03.002. Epub 2007 May 21.
6
[Prolongation of latency or overall treatment time by unplanned radiation pauses. The clinical importance of compensation].
Strahlenther Onkol. 2005 Feb;181(2):65-76. doi: 10.1007/s00066-005-1331-9.
7
70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808.对于局限期小细胞肺癌，70 Gy胸部放疗与化疗同步进行是可行的：癌症与白血病B组研究39808分析
Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):460-8. doi: 10.1016/j.ijrobp.2003.10.021.
8
Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide.在同步接受顺铂和依托泊苷治疗的局限期小细胞肺癌中，每日两次胸部放疗与每日一次胸部放疗的比较。
N Engl J Med. 1999 Jan 28;340(4):265-71. doi: 10.1056/NEJM199901283400403.
9
Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study.
Radiother Oncol. 1997 Nov;45(2):159-66. doi: 10.1016/s0167-8140(97)00151-5.
10
Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy.
Radiother Oncol. 1996 Feb;38(2):89-101. doi: 10.1016/0167-8140(95)01689-9.